USANA Health Sciences, Inc. (NYSE:USNA) Shares Bought by Old Mutual Global Investors UK Ltd.

Old Mutual Global Investors UK Ltd. grew its holdings in USANA Health Sciences, Inc. (NYSE:USNA) by 29.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 239,680 shares of the company’s stock after purchasing an additional 54,831 shares during the period. Old Mutual Global Investors UK Ltd. owned about 0.96% of USANA Health Sciences worth $15,363,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the company. Alps Advisors Inc. increased its holdings in shares of USANA Health Sciences by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 8,349 shares of the company’s stock valued at $535,000 after purchasing an additional 22 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of USANA Health Sciences by 1.2% in the 1st quarter. JPMorgan Chase & Co. now owns 16,044 shares of the company’s stock valued at $924,000 after purchasing an additional 196 shares during the period. Clinton Group Inc. increased its holdings in shares of USANA Health Sciences by 4.9% in the 1st quarter. Clinton Group Inc. now owns 5,238 shares of the company’s stock valued at $302,000 after purchasing an additional 245 shares during the period. BNP Paribas Arbitrage SA increased its holdings in shares of USANA Health Sciences by 13.1% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock valued at $135,000 after purchasing an additional 245 shares during the period. Finally, Legal & General Group Plc increased its holdings in shares of USANA Health Sciences by 7.6% in the 2nd quarter. Legal & General Group Plc now owns 4,040 shares of the company’s stock valued at $259,000 after purchasing an additional 284 shares during the period. Institutional investors own 44.90% of the company’s stock.

In other USANA Health Sciences news, Director Myron W. Wentz sold 40,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 5th. The stock was sold at an average price of $64.15, for a total transaction of $2,566,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, major shareholder Global Ltd Gull sold 79,294 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $57.61, for a total value of $4,568,127.34. Following the transaction, the insider now directly owns 12,272,013 shares in the company, valued at approximately $706,990,668.93. The disclosure for this sale can be found here. In the last three months, insiders sold 323,326 shares of company stock worth $18,920,590. 53.20% of the stock is owned by insiders.

Several equities research analysts recently commented on USNA shares. BidaskClub cut USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research note on Monday, July 31st. Pivotal Research lowered their price target on USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a research note on Wednesday, July 26th.

Shares of USANA Health Sciences, Inc. (USNA) opened at 57.50 on Friday. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $75.00. The company has a 50 day moving average price of $57.59 and a 200 day moving average price of $60.18. The company has a market cap of $1.41 billion, a PE ratio of 14.94 and a beta of 1.10.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, July 25th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.06 by ($0.08). USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. The firm had revenue of $257.10 million during the quarter, compared to analyst estimates of $273.61 million. During the same period in the prior year, the business posted $2.07 EPS. The firm’s quarterly revenue was down .5% compared to the same quarter last year. On average, equities analysts expect that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current year.

USANA Health Sciences declared that its Board of Directors has approved a stock buyback program on Tuesday, July 25th that allows the company to buyback $64.60 million in shares. This buyback authorization allows the company to repurchase up to 46% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s management believes its stock is undervalued.

WARNING: “USANA Health Sciences, Inc. (NYSE:USNA) Shares Bought by Old Mutual Global Investors UK Ltd.” was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://stocknewstimes.com/2017/09/15/old-mutual-global-investors-uk-ltd-has-15-36-million-position-in-usana-health-sciences-inc-usna.html.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply